Hello everyone
I trust everyone is doing well and things are all under control! This is a bit of a strange post, but maybe someone can share some advice on an issue that I think we all encounter from time to time - that is, how to get a haematologist to listen to us and not to dismiss our research as a Google search by an uninformed patient.
For example, there is a great deal of evidence (championed here by scuba) that lower doses of dasatinib are effective and there are several scholarly articles that prove this. Yet, many of us find it impossible to get our doctors to even think of putting us on a lower dose, especially if the side effects we live with aren't deemed harmful. However, these side effects could perhaps be reduced if we were able to go on 50mg or even 70mg, and there is enough evidence that this may work.
I fully understand that my Google search is not to be confused with my doctor's medical degree, and I defer to the knowledge of the experts. I also fully understand that there is a great deal of nonsense and quackery on the web (here I'm thinking of a friend who is hell-bent on selling me anti-candida treatments and urging me to come off the imatinib). At the same time, though, many of our doctors are not specifically CML experts (like Dr Druker and Dr Cortes), and our condition is simply one of a very diverse range of illnesses and conditions that they treat. Also, our condition is so very well controlled with the medication, in most cases, that there is no real need for busy specialists to spend time reading articles that provide a very small benefit, whereas there are several other serious conditions that (rightly) command their attention. So it is understandable that not all doctors have read the latest research - it affects us as patients directly, but is only a small part of the extremely important work that these haematologists do (I'm thinking, for example, of the over 40 different types of lymphoma that these professionals have to diagnose and treat on a daily basis).
Anyway, the purpose of this thread is to ask how to go about bringing significant and relevant research to the attention of the haematologist without (1) intruding on their time and (2) appearing to "know better" (which is certainly not the case). It is so important to maintain respect and trust between the doctor and patient, and I would never dream of superseding the authority of my doctor. The point is simply that, if better options exist, one might be able to try them to everyone's benefit (I'm thinking here of the enormous saving to the economy if most patients could be put on 50 or 20mg dasatinib).
Any thoughts would be welcome!
Best wishes from South Africa, where spring is in the air!
Martin